Emese M.
- Country
- Hungary
- Department
- Clinical Center, 1st Department of Internal Medicine, Department of Endocrinology and Metabolism
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Eneboparatide (AZP-3601) Efficacy and Safety in Chronic Hypoparathyroidism Patients
- Phase II Open-Label Study on Safety, Tolerability, Pharmacokinetics, and Efficacy of AG13909 in Adults with Cushing's Disease
Data & Insights
Has run more than one trial at 55 of 147 partner sites.
Specializations
Endocrine Disorders
This investigator specializes in the treatment of complex endocrine disorders, with particular emphasis on pituitary gland disorders and related hormonal conditions.
- Acromegaly Management
- Cushing's Disease Treatment
- Hormonal Regulation
The investigator explores innovative therapeutic approaches for patients with challenging endocrine conditions.
Hormone-Related Therapeutics
Focused on developing and evaluating novel therapeutic agents for patients with hormone-related disorders, particularly those affecting growth hormone and cortisol regulation.
- Growth Hormone Regulation
- IGF-1 Response Assessment
- Cortisol Level Management
The research encompasses long-term safety and efficacy evaluations of emerging therapeutic options.
Calcium Homeostasis
Investigates treatments for disorders affecting calcium metabolism and parathyroid function, with specific attention to chronic conditions.
- Hypoparathyroidism Treatment
- Calcium Level Regulation
- Vitamin D Management
The investigator evaluates therapeutic interventions for maintaining optimal calcium homeostasis in patients with endocrine disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.